SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY

被引：0
|
作者：
Kivitz, A. [1 ]
Gottenberg, J. E. [2 ]
Bergman, M. [3 ]
Iglesias-Rodriguez, M. [4 ]
St John, G. [5 ]
Qiu, C. [6 ]
Van Hoogstraten, H. [6 ]
Bessette, L. [7 ]
机构：
[1] Altoona Ctr Clin Res, Duncansville, PA USA
[2] Hop Univ Strasbourg, Strasbourg, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, NJ USA
[7] Laval Univ, Quebec City, PQ, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.1972
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0301
引用
收藏
页码：1446 / 1446
页数：1
相关论文
共 50 条
  • [41] Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure
    Blanco, Francisco J.
    Rubio-Romero, Esteban
    Sanmarti, Raimon
    Diaz-Torne, Cesar
    Talavera, Pablo
    Dunkel, Jochen
    Naredo, Esperanza
    REUMATOLOGIA CLINICA, 2020, 16 (05): : 345 - 352
  • [42] Update results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase II clinical trial
    Wang, J.
    Wu, T.
    Hong, Y-G.
    Luo, S-X.
    Li, N.
    Guo, Y-Z.
    Cheng, Y-F.
    ANNALS OF ONCOLOGY, 2021, 32 : S1058 - S1058
  • [43] Anakinra, A recombinant human interleukin-1 receptor antagonist, in combination with conventional immunosuppressive dmards, for severe rheumatoid arthritis: Interim analysis of an ongoing, 12 month, open-label, three-arm study
    Karanikolas, G. N.
    Karras, D.
    Zervas, K.
    Rapti, A.
    Charalambopoulos, D.
    Andrianakos, A.
    Kaskani, E.
    Gazi, S.
    Mortsikas, C.
    Stavropoulos, E.
    Tsiakou, E.
    Augoustinaki, M.
    Lagoudakis, A.
    Karlou, E.
    Akkizidou, A.
    Sfiroera, A.
    Papachronis, J.
    Hatzilouloudis, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 322 - 322
  • [44] EFFICACY AND SAFETY OF ZIMBERELIMAB (GLS-010) MONOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II STUDY
    Wu, Xiaohua
    Xia, Lingfang
    Wang, Jing
    Wang, Chunyan
    Zhang, Qingming
    Zhu, Jianqing
    Rao, Qunxian
    Cheng, Huijun
    Liu, Zheng
    Yin, Yongmei
    Ai, Xiaohong
    Gulina, Kurban
    Zheng, Hong
    Luo, Xiaoyong
    Chang, Baoping
    Li, Li
    Liu, Haiyan
    Li, Yunxia
    Lou, Ge
    Zhou, Qi
    Zhu, Yanling
    Xiao, Zemin
    Tong, Jiandong
    Wang, Ke
    Chen, Jie
    Wang, Xia
    Song, Lijie
    Wei, Zhixia
    Ye, Yijing
    Zhu, Jiman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A703 - A703
  • [45] Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
    Wu, X.
    Xia, L.
    Wang, J.
    Wang, C.
    Zhang, Q.
    Zhu, J.
    Rao, Q.
    Cheng, H.
    Liu, Z.
    Yin, Y.
    Ai, X.
    Gulina, K.
    Zheng, H.
    Luo, X.
    Chang, B.
    Li, L.
    Liu, H.
    Li, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [46] Possible Role of Platelet-Rich Plasma in the Treatment of Patients with Postherpetic Neuralgia: A Prospective, Single-Arm, Open-Label Clinical Study
    Abu El-Hamd, Mohammed
    Abd Elaa, Shereen G.
    Abdelwahab, Ashraf
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (06) : 986 - 991
  • [47] Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
    Fleseriu, Maria
    Iweha, Chioma
    Salgado, Luiz
    Mazzuco, Tania Longo
    Campigotto, Federico
    Maamaris, Ricardo
    Limumpornpetch, Padiporn
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [48] Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
    Leger, Jean-Marc
    De Bleecker, Jan L.
    Sommer, Claudia
    Robberecht, Wim
    Saarela, Mika
    Kamienowski, Jerzy
    Stelmasiak, Zbigniew
    Mielke, Orell
    Tackenberg, Bjoern
    Shebl, Amgad
    Bauhofer, Artur
    Zenker, Othmar
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2013, 18 (02) : 130 - 140
  • [49] Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study
    Shi, Yuan-Kai
    Hong, Xiao-Nan
    Yang, Jian-Liang
    Xu, Wei
    Huang, Hui-Qiang
    Xiao, Xiu-Bin
    Zhu, Jun
    Zhou, Dao-Bin
    Han, Xiao-Hong
    Wu, Jian-Qiu
    Zhang, Ming-Zhi
    Jin, Jie
    Ke, Xiao-Yan
    Li, Wei
    Wu, De-Pei
    Yang, Shen-Miao
    Du, Xin
    Jia, Yong-Qian
    Liu, Ai-Chun
    Liu, Dai-Hong
    Shen, Zhi-Xiang
    Zhang, Lian-Sheng
    James, Leonard
    Hellriegel, Edward
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1299 - 1309
  • [50] Safety and efficacy of leflunomide plus etanercept combination therapy in patients with rheumatoid arthritis:: Results from an open-label pilot study
    Grünke, M
    Kalden, JR
    Manger, B
    Antoni, CE
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 421 - 421
12345